CDKN1B and hematologic disorder: High levels of miR-181a and miR-221 also point to cell cycle progression as both miRNAs repress CDKN1B (p27) expression in hematologic diseases [23,50] and p27 was also found down-regulated in resistant cells (Additional file 5).